374water Inc. (SCWO) — SEC Filings
374water Inc. (SCWO) — 44 SEC filings. Latest: 8-K (Dec 15, 2025). Includes 25 8-K, 6 10-Q, 4 DEFA14A.
View 374water Inc. on SEC EDGAR
Overview
374water Inc. (SCWO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 15, 2025: On December 14, 2025, 374Water Inc. announced the departure of Director Dr. Robert L. Smith and the appointment of Dr. Emily Carter as a new director. The company also disclosed compensatory arrangements for certain officers, details of which are included in the filing.
Sentiment Summary
Across 44 filings, the sentiment breakdown is: 6 bearish, 38 neutral. The dominant filing sentiment for 374water Inc. is neutral.
Filing Type Overview
374water Inc. (SCWO) has filed 25 8-K, 4 DEFA14A, 6 10-Q, 3 DEF 14A, 3 8-K/A, 2 10-K, 1 SC 13D/A with the SEC between Mar 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (44)
Risk Profile
Risk Assessment: Of SCWO's 40 recent filings, 6 were flagged as high-risk, 20 as medium-risk, and 14 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $1,898,484 |
| Net Income | $(12,627,886) |
| EPS | N/A |
| Debt-to-Equity | 0.75 |
| Cash Position | $933,328 |
| Operating Margin | N/A |
| Total Assets | $11,362,173 |
| Total Debt | $4,865,112 |
Key Executives
- Dr. Robert L. Smith
- Dr. Emily Carter
- Deanna Rene Estes
- Stephen J. Jones
- CEO
- Dr. Michael J. Weber
- Ms. Jennifer L. DeSimone
- Yaacov Nagar
- Mr. David L. Chen
Industry Context
The wastewater treatment industry is undergoing innovation, with a growing focus on sustainable and efficient technologies. Companies like 374Water are developing advanced solutions to address environmental concerns and regulatory pressures. However, the sector also faces competition from established players and requires significant capital investment for technology development and deployment.
Top Tags
corporate-governance (8) · filing (7) · officer-compensation (4) · 10-Q (4) · sec-filing (4) · 8-k (4) · 8-K (4) · director-change (3) · proxy-statement (3) · amendment (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $1.9M | Increased 337.9% for the nine months ended September 30, 2025, from $433,589 in 2024. |
| Net Loss | $(12.6M) | Widened by 64.9% for the nine months ended September 30, 2025, from $(7.7M) in 2024. |
| Cash Balance | $933K | Decreased 91.2% from $10.65M at December 31, 2024, to $933,328 at September 30, 2025. |
| Cash Used in Operations | $10.2M | For the nine months ended September 30, 2025, up from $7.5M in 2024. |
| Total Operating Expenses | $12.9M | Increased 67.2% for the nine months ended September 30, 2025, from $7.7M in 2024. |
| Compensation and Related Expenses | $5.8M | More than doubled for the nine months ended September 30, 2025, from $3.0M in 2024. |
| Proceeds from Common Stock Sales | $1.9M | Net of issuance costs, for the nine months ended September 30, 2025. |
| Equipment-in-progress | $1.2M | Costs for the AirSCWO1 (AS1) model as of September 30, 2025. |
| Shares Outstanding | 169,248,799 | As of November 12, 2025. |
| Accumulated Deficit | $(41.0M) | Increased from $(28.4M) at December 31, 2024, to $(41.0M) at September 30, 2025. |
| Nasdaq Minimum Bid Price | $1.00 | SCWO's stock has been trading below this threshold for over 30 days, triggering non-compliance. |
| Reverse Stock Split Ratio Range | 1-for-8 to 1-for-20 | The proposed range for the reverse stock split, aimed at increasing share price. |
| Special Meeting Date | December 15, 2025 | Date stockholders will vote on the reverse stock split and adjournment proposals. |
| Nasdaq Compliance Deadline | January 12, 2026 | The date by which SCWO must regain compliance with Nasdaq's minimum bid price requirement. |
| Non-Compliance Notification Date | July 16, 2025 | Date SCWO disclosed receiving the Nasdaq minimum bid price non-compliance notice. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for 374water Inc. (SCWO)?
374water Inc. has 44 recent SEC filings from Mar 2024 to Dec 2025, including 25 8-K, 6 10-Q, 4 DEFA14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SCWO filings?
Across 44 filings, the sentiment breakdown is: 6 bearish, 38 neutral. The dominant sentiment is neutral.
Where can I find 374water Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all 374water Inc. (SCWO) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for 374water Inc.?
Key financial highlights from 374water Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SCWO?
The investment thesis for SCWO includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at 374water Inc.?
Key executives identified across 374water Inc.'s filings include Dr. Robert L. Smith, Dr. Emily Carter, Deanna Rene Estes, Stephen J. Jones, CEO and 4 others.
What are the main risk factors for 374water Inc. stock?
Of SCWO's 40 assessed filings, 6 were flagged high-risk, 20 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from 374water Inc.?
Forward guidance and predictions for 374water Inc. are extracted from SEC filings as they are enriched.